Japanese University Contract Clinical Study Revenues From Drug Makers Continue To Grow
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Education, Culture, Sports, Science and Technology released a report August 7 showing that public and private university revenues from drug makers for contract clinical studies continue to grow, increasing 8 percent to ¥17.9 billion last year